Daniel A Spyker

Title: Innovations by Daniel A Spyker in Pain Management

Introduction

Daniel A Spyker is an accomplished inventor based in Burlingame, CA (US). He has made significant contributions to the field of pain management, particularly through his innovative use of buprenorphine. With a total of 3 patents to his name, Spyker's work focuses on improving treatment regimens for patients suffering from withdrawal symptoms and pain associated with sickle cell disease.

Latest Patents

Spyker's latest patents include a method for treating dependence withdrawal in pregnant patients. This method involves the transdermal administration of buprenorphine to effectively reduce withdrawal symptoms. The regimen consists of a first buprenorphine-containing transdermal dosage form administered for no more than about 5 days, followed by a second dosage form with the same or a greater dosage for another 5 days, and a third dosage form for at least 2 days, also with an equal or greater dosage.

Another notable patent addresses the use of transdermal buprenorphine for pain relief during sickle cell crises. This specific dosage regimen includes administering at least one BTDS transdermal patch to patients in need of pain relief. The regimen may involve a series of buprenorphine-containing transdermal dosage forms, each with increasing dosages to ensure effective pain management.

Career Highlights

Daniel A Spyker is currently associated with Purdue Pharma L.P., where he continues to develop innovative solutions for pain management. His work has been instrumental in advancing treatment options for patients facing challenging health conditions.

Collaborations

Spyker collaborates with Bruce Reidenberg, contributing to the development of effective treatment methodologies in their field.

Conclusion

Daniel A Spyker's innovative patents and dedication to improving pain management highlight his significant role in the medical field. His contributions are paving the way for better treatment options for patients in need.